chr20-20036212-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001278628.2(CRNKL1):c.2047G>A(p.Asp683Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000538 in 1,613,920 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D683A) has been classified as Uncertain significance.
Frequency
Consequence
NM_001278628.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CRNKL1 | NM_001278628.2 | c.2047G>A | p.Asp683Asn | missense_variant | 14/14 | ENST00000536226.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CRNKL1 | ENST00000536226.2 | c.2047G>A | p.Asp683Asn | missense_variant | 14/14 | 1 | NM_001278628.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152188Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000307 AC: 77AN: 250888Hom.: 0 AF XY: 0.000302 AC XY: 41AN XY: 135576
GnomAD4 exome AF: 0.000564 AC: 824AN: 1461732Hom.: 0 Cov.: 30 AF XY: 0.000524 AC XY: 381AN XY: 727162
GnomAD4 genome AF: 0.000296 AC: 45AN: 152188Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2023 | The c.2530G>A (p.D844N) alteration is located in exon 15 (coding exon 15) of the CRNKL1 gene. This alteration results from a G to A substitution at nucleotide position 2530, causing the aspartic acid (D) at amino acid position 844 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at